| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Market Size (2025) | USD 387.58 Million |
| Market Size (2030) | USD 506.31 Million |
| CAGR (2025 - 2030) | 5.49 % |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
China Magnetic Resonance Imaging Market Analysis
The China Magnetic Resonance Imaging Market size is estimated at USD 387.58 million in 2025, and is expected to reach USD 506.31 million by 2030, at a CAGR of 5.49% during the forecast period (2025-2030).
COVID-19 pandemic has severely affected all the sectors in China during the initial wave of the disease. The market study was greatly hampered during the year 2020 as a result of restrictions on non-emergency diagnostic or therapeutic services in the hospitals. However, as the experts started understanding the coronavirus and its progression in the human body and how it affects the vital organs, several diagnostic approaches and tests came into the picture. For instance, MRI or CT scans were largely being used for diagnosis of COVID-19 infection in the lungs or its impact on the brain in some cases. This has helped the magnetic resonance imaging market to keep its momentum steady during the pandemic. The MRI scans provide a reliable and accurate result of an infection that occurred in the lungs or other parts of the body which is enabling early diagnosis of the disease. Therefore, currently, the market is achieving benefits from COVID-19 and is believed to grow over the forecast period as all the elective diagnostics and therapeutic procedures have started in the country in 2021. According to an article named 'Insights Into Neuroimaging Findings of Patients With COVID-19 Presenting With Neurological Manifestations' published in 2020, several people had a mild case of the disease that went away without therapy. Other systems, particularly the central nervous system, were commonly involved in severely ill patients. An increasing number of individuals with COVID-19 who had neurological signs have been documented as a result of this study's understanding of SARS-CoV-2. In a retrospective, observational research from Wuhan, China, 36 % of the 214 consecutive COVID-19 patients developed neurological symptoms. Using this neuroimaging, 59 % of COVID-19 patients had neurological symptoms, and brain MRI revealed a variety of neuroimaging abnormalities. Notably, approximately 41% of COVID-19 patients with available neuroimaging had normal results. MRI neuroimaging is a well-proven method to identify the post-covid effects expected to increase the MRI market due to Covid in this region.
China is one of the most populous countries in the world and has one of the highest burdens of chronic diseases around the world, which is the primary factor driving the growth of the magnetic resonance imaging (MRI) market in the country. According to the seventh Chinese national census of 2020, individuals aged 60 years and above and those aged over 65 years totaled 264,018,766 and 190,635,280, accounting for 18.70% and 13.50% of the population, respectively. A high number of the older population indicate a high risk of chronic diseases in the country as old people are more prone to various diseases such as cardiovascular conditions and other chronic diseases. Therefore, the increasing geriatric population is acting as one of the leading factors for the growth of the market studied in the future.
China Magnetic Resonance Imaging Market Trends
Oncology is Expected to Witness Strong Growth Over the Forecast Period
Magnetic resonance imaging (MRI) is an imaging test that may be used to detect tumor/cancerous cells in the body. It may also be used to look for signs that cancer may have metastasized (spread) from where it started to another part of the body. MRI system uses powerful magnets and radio waves to make detailed, computer-generated cross-section pictures of the body which are later used by doctors in the diagnosis of cancerous cell/tissue.
As per the latest data from Globocan i.e., the year 2020, China has one of the highest burdens of cancer globally. The incidence of cancer is further rising in the country, which is expected to drive the growth of the oncology segment in the magnetic resonance imaging market in China over the years. For instance, as per the same report mentioned above, China reported 4,568,754 new cases of cancer in 2020, and the total number of five-year prevalent cases of cancer was 9,294,006, and the major forms of cancer prevalent in the country were lung (815,563), colorectum (555,477), stomach (478,508), breast (416,371), and liver (410,038) cancer.
Furthermore, as per the same report, it is projected that the cases of cancer may reach 5,811,629 by 2030 and 6,845,787 by 2040, which shows a tremendous increase in the cases of cancer in the country, due to which the demand for MRI scans is expected to increase in the country that may drive the growth of the studied segment in the MRI market.
Additionally, the presence of some of the key market leaders in the country and new product launches and collaborations are also expected to have a positive impact on the oncology segment in the country over the years. For instance, in June 2021, the Chinese University of Hong Kong and Aurora Medical Technology Hong Kong collaborated on the breast cancer research program. The joint project is expected to investigate the potential advantages and challenges of using breast-dedicated MRI for first-line breast cancer screening in Chinese women with dense breasts, for whom the efficacy of mammographic screening is significantly reduced.
Thus, owing to the factors mentioned above, the oncology segment in the magnetic resonance imaging (MRI) market is expected to grow in China.
Understand The Key Trends Shaping This Market
Download PDF
China Magnetic Resonance Imaging Industry Overview
China magnetic resonance imaging market is highly competitive and consists of several major players. In terms of market share, a few of the major players currently dominate the market. However, with technological advancements and quality service provisions, mid-size to smaller companies are increasing their market presence by introducing new products at less prices. Companies, like Siemens Healthineers, GE Healthcare, Canon Medical Systems, and Philips Healthcare, hold a significant market share in the global magnetic resonance imaging market.
China Magnetic Resonance Imaging Market Leaders
-
Siemens AG
-
Canon Medical Systems
-
GE Healthcare
-
Koninklijke Philips NV
-
JiangSu Magspin Instrument Co. Ltd
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competitors?
Download PDF
China Magnetic Resonance Imaging Market News
- In June 2021, the Chinese University of Hong Kong and Aurora Medical Technology Hong Kong collaborated on the breast cancer research program. The joint project was expected to investigate the potential advantages and challenges of using breast-dedicated MRI for first-line breast cancer screening in Chinese women with dense breasts, for whom the efficacy of mammographic screening is significantly reduced.
- In July 2021, Neusoft Medical launched NeuMR Libra MRI at the China International Medical Equipment Fair in Shangai.
China Magnetic Resonance Imaging Industry Segmentation
As per the scope of this report, magnetic resonance imaging is a medical imaging technique, which is used in radiology to produce pictures of the anatomy and the physiological processes of the body. These pictures are further used to diagnose and detect the presence of abnormalities in the body. China Magnetic Resonance Imaging (MRI) Market is segmented by Architecture (Closed MRI Systems and Open MRI Systems), Field Strength (Low Field MRI Systems, High Field MRI Systems, Very High Field MRI Systems and Ultra-high MRI Systems), Application (Oncology, Neurology, Cardiology, Gastroenterology, Musculoskeletal, and Other Applications). The report offers the value (in USD million) for the above segments.
| By Architecture | Closed MRI Systems |
| Open MRI Systems | |
| By Field Strength | Low Field MRI Systems |
| High Field MRI Systems | |
| Very High Field MRI Systems and Ultra-high MRI Systems | |
| By Application | Oncology |
| Neurology | |
| Cardiology | |
| Gastroenterology | |
| Musculoskeletal | |
| Other Applications |
Need A Different Region or Segment?
Customize Now
China Magnetic Resonance Imaging Market Research FAQs
How big is the China Magnetic Resonance Imaging Market?
The China Magnetic Resonance Imaging Market size is expected to reach USD 387.58 million in 2025 and grow at a CAGR of 5.49% to reach USD 506.31 million by 2030.
What is the current China Magnetic Resonance Imaging Market size?
In 2025, the China Magnetic Resonance Imaging Market size is expected to reach USD 387.58 million.
Who are the key players in China Magnetic Resonance Imaging Market?
Siemens AG, Canon Medical Systems, GE Healthcare, Koninklijke Philips NV and JiangSu Magspin Instrument Co. Ltd are the major companies operating in the China Magnetic Resonance Imaging Market.
What years does this China Magnetic Resonance Imaging Market cover, and what was the market size in 2024?
In 2024, the China Magnetic Resonance Imaging Market size was estimated at USD 366.30 million. The report covers the China Magnetic Resonance Imaging Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the China Magnetic Resonance Imaging Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
China Magnetic Resonance Imaging Industry Report
Statistics for the 2025 China Magnetic Resonance Imaging market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. China Magnetic Resonance Imaging analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
